Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Sahand Hormoz
MPN
Craig Jordan
AML
Adi Nagler
Bronchiolitis obliterans after transplant
William Matsui
Myeloma
Mark Hamilton
DLBCL and CAR-T
Qing Yi
Novel CAR-T
Joachim Yahalom
Lymphoma
Christian Steidl
B-cell lymphomas
Madhav Dhodapkar
multiple myeloma immunotherapy
Marc Seifert
Hairy cell leukemia
Nirav Shah
CAR-T for lymphoma
Luca Busino
DLBCL
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Frederick Locke
lymphoma and immunotherapy
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Grant Challen
preleukemia, leukemia
Oreofe Odejide
Equity in Access
Christopher Booth
BPDCN
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Koichi Takahashi
AML/MDS
Philippe Armand
follicular lymphoma
Steven Treon
Lymphomas and Waldenstrom's
Jake Shortt
precision therapy for aggressive lymphomas
Julia Paczkowska
immunobiology of Hodgkin's disease
Jeremy Baeten
AML
Sham Mailankody
Myeloma immunotherapy clinical trials
John Crispino
myelofibrosis, pediatric leukemia and Downs
ImCheck Therapeutics
immunotherapy, AML
Ari Melnick
epigenetics and lymphoma
Faron Pharmaceuticals
immunotherapy, MDS
Gaurav Goyal
Erdheim-Chester Disease
F. Lennie Wong
Equity in Access
Tomasz Skorski
myeloproliferative neoplasms, AML
Paolo Strati
Non-Hodgkin Lymphoma
Srividya Swaminathan
pediatric, immunotherapy
Meng Li
Equity in Access
George Vassiliou
Leukemia Prevention
Ricky Johnstone
lymphoma and myeloma
Amit Verma
AML/MDS
Justine Kahn
pediatric leukemia and lymphoma
H. Irene Su
Equity in Access
Trent Hall
MDS
Ann-Kathrin Eisfeld
Racial diversity in AML
Sriram Sundaravel
AML stem cells
Rajni Kumari
AML
Daisuke Nakada
preleukemia, leukemia
Kura Oncology
MLL leukemia, AML
Christine Zhang
AML
Eugenio Morelli
Myeloma
Shazia Nakhoda
Equity in Access
BioInvent International
immunotherapy, indolent NHL, CTCL
Jing Yang
Myeloma
Liling Wan
AML
Yan Liu
MDS
Thomas Koehnke
leukemia
Marco Ruella
Immunotherapy for T-cell lymphoma
Nicolas Nassar
pediatric leukemia
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Adam Olszewski
Follicular and marginal zone lymphoma
Richard Lock
T-ALL
Lawrence Boise
CART and myeloma
Tanya Siddiqi
clinical trial access
Matteo Bellone
Smoldering multiple myeloma
Mendel Goldfinger
MDS/AML trials for the elderly
Jonathan Licht
DNA biology, myeloma
Peter Klein
MDS
Yibin Yang
Lymphoma
Christopher Flowers
clinical trial access
Sheng Li
Aging and AML
Lindsey Montefiori
pediatric leukemia
Ronald Levy
immunotherapies, COVID-19
Britta Will
Leukemia and pre-leukemia
Daniel Pollyea
AML
Megan McNerney
AML/MDS
Christian Marinaccio
MLL leukemias
Yiman Liu
Epigenetics and leukemia
Jayna Mistry
aging and leukemias
Martin Dreyling
Mantle Cell Lymphoma
Jonas Jutzi
myeloproliferative neoplasms
Stacie Dusetzina
Equity in Access
Kerry Rogers
CLL
Paolo Caimi
CAR-T clinical trial for CLL
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Coleman Lindsley
AML/MDS
Jianhua Yu
myeloma immunotherapy
Sergei Doulatov
Leukemias
Bing Carter
p53 mutant AML
John Leonard
lymphoma research
Robert Orlowski
(Smoldering) Multiple Myeloma
Takeshi Sugio
T-cell lymphoma
Ruben Carrasco
Myeloma
Reina Takeda
AML
George Daley
"off-the-shelf" CAR-T and CAR-NK
Mala Shanmugam
myeloma
Dane Vassiliadis
blood cancer biology
Nicoletta Cieri
AML and transplantation
Pietro Genovese
transplant and AML
Anushree Vichare
Equity in Access
Ravindra Majeti
preleukemia, AML
Courtney Jones
AML metabolism
Nataly Cruz-Rodriguez
T-ALL and metabolism
Mark Murakami
follicular lymphoma
Riccardo Dalla-Favera
lymphoma (DLBCL)
Jalpa Doshi
Equity in Access
Jenny Wang
AML
Saar Gill
AML immunotherapy
James Rubenstein
Lymphoma of the Central Nervous System
Leandro Cerchietti
DLBCL
Neha Mehta-Shah
T-cell lymphoma
Michael Wang
Mantle Cell Lymphoma
Michael Green
lymphoma biology
Jennifer Amengual
lymphomas after transplant
Alieen Rowan
Adult T cell leukemia/lymphoma
Yoke Seng Lee
AML
Manyi Wei
acute megakaryoblastic leukemia
Logan Spector
childhood leukemia epidimiology
Steven Horwitz
T-cell lymphomas
Jianguo Tao
Mantle Cell Lymphoma
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
John DiPersio
trispecific antibody for AML and MDS
Caner Saygin
T-ALL
Carma Bylund
Equity in Access
Huda Salman
CMML
Kathleen Sakamoto
pediatric AML
Thomas Kipps
Hairy Cell Leukemia
Ana Vujovic
AML
Daniel Herranz
T-ALL
Anthony Letai
improving CAR-T
Brian Dalton
DNA mutations and myeloid cancers
Michaela Reagan
Multiple Myeloma
Omar Abdel-Wahab
Hairy cell leukemia
Daniel Thomas
Myelofibrosis
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Armin Rashidi
gut bacteria and transplant success
Yubin Zhou
peripheral T cell lymphoma
Grzegorz Nowakowski
Clinical trial access
Tyler Parsons
MPN and AML
Rgenta Therapeutics
RNA-targeting, blood cancer
Jaehyuk Choi
T-cell lymphoma
Margaret Shipp
lymphoma biology
Robert Soiffer
transplantation
Maximilian Stahl
AML immunotherapy
Keisuke Ito
blood cancer stem cells and MDS metabolism
Fenghuang Zhan
Myeloma and bone disease
Alfred Garfall
myeloma immunotherapy
Thomas LeBlanc
palliative care
Courtney DiNardo
clinical trials, AML
Suman Paul
T cell cancers and immunotherapy
Enrico Tiacci
Hairy cell leukemia
Soheil Meshinchi
pediatric AML
Brian Walker
smoldering myeloma, MGUS
Nicola Vannini
Aging and CAR-T success
Eric Padron
CMML
Steven Park
follicular lymphoma
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Paul Beavis
immunotherapy in myeloma
Stephen Gottschalk
pediatric leukemia and CAR-T
Rizwan Romee
Immunotherapy
Eric Pietras
AML
Rong Lu
preleukemia, leukemia
Mark Dawson
B-ALL and CAR-T resistance
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Pooja Khandelwal
bone marrow transplantation
Jun Qi
Myeloma
Carl Allen
pediatric blood cancers
Michael Kharas
leukemia
Peter Croucher
Multiple Myeloma
Nizar Bahlis
Myeloma immunotherapy
Enterome
vaccine, FL, MZL
Matthew Frank
Lymphoma CART therapy
Tak Mak
Immunotherapy
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Jennifer Trowbridge
aging and leukemia
Bruno Paiva
smoldering myeloma
Jean Koff
Disparities in DLBCL
Shannon Maude
Immunotherapy for ALL
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Kimberly Stegmaier
childhood blood cancers
Lucy Godley
preleukemia
Hao Jiang
DNA biology and leukemia
Qingyu Luo
BPDCN
Julia Maxson
AML
Bingyi Chen
AML immunotherapy
Nitin Jain
CLL
Sam Butterworth
CMML
Raymond Mailhot
Equity in Access
Adam de Smith
pediatric ALL and Down Syndrome
Ravi Bhatia
transplantation
Helen Parsons
Equity in Access
Solu Therapeutics
immunotherapy, CMML
Jennifer Woyach
CLL trials
Urvi Shah
Diet and myeloma
Sigurður Kristinsson
Smoldering myeloma
Roberta Zappasodi
lymphoma, immunotherapy
Markus Muschen
leukemia and lymphoma biology
Stephen Nimer
myeloid cancer biology
Alexey Danilov
lymphoma
Kirk Schultz
pediatric transplantation
Dimericon Therapeutics
dimericons, blood cancer
Michael Savona
MDS and leukemia
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Alex Kentsis
pediatric leukemias
Anouchka Laurent
T-cell lymphoma
Eirini Papapetrou
blood cancer stem cells
Catriona Jamieson
cancer stem cell biology
Jonathon Cohen
lymphoma clinical trial access in Georgia
Catherine Bollard
pediatric blood cancers and immunotherapy
Timothy Graubert
AML and MDS biology
Carl June
CAR T immunotherapy
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Wendy Stock
T-cell ALL
Gianpietro Dotti
CAR T and AML
Simona Colla
Myeloma biology
Siegfried Janz
Myeloma immunotherapy
Jolanta Grembecka
leukemia therapeutics
Jeetayu Biswas
splicing in myeloid diseases
Noemí Puig Morón
Myeloma
Suzanne Lentzsch
Myeloma
Tycel Phillips
Mantle Cell Lymphoma
Venkata Lokesh Battula
immunotherapy and AML
Catherine Diefenbach
DLBCL immunology
Constellation Pharmaceuticals
myeloproliferative neoplasms
Rachel Mersfelder
AMKL
Cailin Collins
Leukemia and pre-leukemia
Wendy Béguelin
follicular lymphoma
Hong Wen
AML
Michael Keller
COVID-19, immunotherapy
Taishi Yonezawa
AML
Randall Davis
CLL
Xu Ji
Equity in Access
Jing Fu
myeloma
Elliot Stieglitz
CMML
Bailee Kain
AML and African ancestry
Siddhartha Jaiswal
preleukemia
Jeffrey Magee
pediatric AML
Piers Patten
COVID-19
Fahmin Basher
transplant and GvHD
Daniel Lucas
bone marrow and leukemia biology
Kasey Leger
pediatric blood cancers
Inhye Ahn
CLL
Lev Kats
myeloma and epigenetics
Liran Shlush
pre-leukemia
Sarah Tasian
pediatric leukemias
Andrew Lane
BPDCN
Caroline Arber
myeloma CAR-T
Marina Konopleva
MDS/AML metabolism
Teresa Palomero
Peripheral T-cell Lymphoma
Christopher Porter
Leukemia, lymphoma
Affimed
immunotherapy, HL, PTCL
Caron Jacobson
lymphoma and immunotherapy
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Lori Muffly
Equity in Access
Jessica Stewart
Epstein-barr virus and lymphomas
Catherine Smith
leukemia
Roland Walter
Antibody-based AML therapies
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Dan Landau
cancer evolution biology